Anti-estrogen plus progestin containing oral contraceptives
作者： Christopher Paul Miller , Michael Jay Gast
DOI:
关键词:
摘要: This invention provides a method of providing contraception which comprises administering to female child bearing age combination non-uterotrophic anti-estrogen and progestin for 28 days per 28-day menstrual cycle.
lens.org 参考文章(13)
Erwin von Angerer, 1-carbamoylalkyl-2-phenylindoles, pharmaceutical compositions and use ,(1989)
Fernand Labrie, Combination therapy for the treatment of estrogen-sensitive disease ,(1991)
Kalevi Heiskanen, Lauri Kangas, A method for controlling a pest population ,(1994)
Arthur A. Santilli, Michael D. Collini, Chris P. Miller, Bach D. Tran, 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents ,(2003)
Yves Merand, Fernand Labrie, Sex steroid activity inhibitors ,(1992)
David B. MacLean, David D. Thompson, Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions ,(1997)
Arthur A. Patchett, William J. Greenlee, Prasun K. Chakravarty, Thomas F. Walsh, Nathan B. Mantlo, Substituted imidazo-fused 6-membered heterocycles as angiotensin ii antagonists ,(1990)
Ulf Norinder, Indole derivatives as anti-estrogens ,(1994)
Klaus Stöckemann, Kristof Chwalisz, Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception ,(1995)
David B. Maclean, David D. Thompson, Combinations of droloxifene with progestins for the treatment of osteoporosis ,(1997)